{"id":{"repo_id":"mit","oai_identifier":"oai:dspace.mit.edu:1721.1/107517"},"canonical_url":"https://search.dev.ndltd.org/etd/mit/oai:dspace.mit.edu:1721.1/107517","repository":{"repo_id":"mit","name":"MIT","base_url":"https://dspace.mit.edu/oai/request"},"display":{"title":"Analyzing tradeoffs between working capital and production capacity for multi-stage manufacturing processes","abstract":"Large pharmaceutical companies struggle to find innovative ways to reduce work-in-process inventory in their production facilities. In our research, we focus on the tradeoff between inventory and production capacity through investing in new facilities and equipment. This tradeoff will depend on the company's objectives and what it is willing to give up in return for reducing inventory. We found that increasing capacity to reduce work-in-process inventory by investing in new facilities is not always the most favorable approach in terms of net present value. However, for flexibility or lead-time improvements, it may make sense to proceed with the investment. We developed multiple scenarios considering the company's future plans to reduce inventory or grow. These scenarios provide insights into the factors that improve the attractiveness of the investments and those that do not. Our financial analysis along with the guidelines and procedures that we have developed help the sponsor company most effectively reach its goal to reduce its work in process inventory.","abstract_html":"Large pharmaceutical companies struggle to find innovative ways to reduce work-in-process inventory in their production facilities. In our research, we focus on the tradeoff between inventory and production capacity through investing in new facilities and equipment. This tradeoff will depend on the company's objectives and what it is willing to give up in return for reducing inventory. We found that increasing capacity to reduce work-in-process inventory by investing in new facilities is not always the most favorable approach in terms of net present value. However, for flexibility or lead-time improvements, it may make sense to proceed with the investment. We developed multiple scenarios considering the company's future plans to reduce inventory or grow. These scenarios provide insights into the factors that improve the attractiveness of the investments and those that do not. Our financial analysis along with the guidelines and procedures that we have developed help the sponsor company most effectively reach its goal to reduce its work in process inventory.","abstract_has_math":false,"creators":["Kamareddine, Karim","Yao, Yihong"],"institution":"Massachusetts Institute of Technology","degree_name":null,"degree_level":null,"degree_discipline":null,"degree_department":"Massachusetts Institute of Technology. Supply Chain Management Program.","school":null,"contributors":[],"advisors":["Jarrod Goentzel."],"committee_chairs":[],"committee_members":[],"year":2016,"date_issued":"2016","date_published":"2016","updated_at":"2026-07-22T22:21:55Z","subjects":["Supply Chain Management Program.","Engineering Systems Division."],"languages":["eng"],"rights":["MIT theses are protected by copyright. They may be viewed, downloaded, or printed from this source but further reproduction or distribution in any format is prohibited without written permission."],"rights_urls":["http://dspace.mit.edu/handle/1721.1/7582"],"identifier_entries":[]},"links":{"outbound_url":"http://hdl.handle.net/1721.1/107517","outbound_label":"Handle","outbound_source":"dc:identifier.uri"},"metadata_groups":[{"id":"people","label":"People","entries":[{"key":"dc:contributor.advisor","label":"Advisor","values":["Jarrod Goentzel."]},{"key":"dc:contributor.department","label":"Department","values":["Massachusetts Institute of Technology. Supply Chain Management Program.","Massachusetts Institute of Technology. Engineering Systems Division."]},{"key":"dc:contributor.other","label":"Dc Contributor Other","values":["Massachusetts Institute of Technology. Engineering Systems Division."]},{"key":"dc:creator","label":"Author","values":["Kamareddine, Karim","Yao, Yihong"]}]},{"id":"academic_context","label":"Academic Context","entries":[{"key":"dc:date.accessioned","label":"Dc Date Accessioned","values":["2017-03-20T19:38:01Z"]},{"key":"dc:date.available","label":"Dc Date Available","values":["2017-03-20T19:38:01Z"]},{"key":"dc:date.issued","label":"Date","values":["2016"]},{"key":"dc:publisher","label":"Institution","values":["Massachusetts Institute of Technology"]},{"key":"dc:type","label":"Dc Type","values":["Thesis"]}]},{"id":"subjects_keywords","label":"Subjects and Keywords","entries":[{"key":"dc:subject","label":"Dc Subject","values":["Supply Chain Management Program.","Engineering Systems Division."]}]},{"id":"language_rights","label":"Language and Rights","entries":[{"key":"dc:language.iso","label":"Language (ISO)","values":["eng"]},{"key":"dc:rights","label":"Dc Rights","values":["MIT theses are protected by copyright. They may be viewed, downloaded, or printed from this source but further reproduction or distribution in any format is prohibited without written permission."]},{"key":"dc:rights.uri","label":"Rights URI","values":["http://dspace.mit.edu/handle/1721.1/7582"]}]},{"id":"identifiers","label":"Identifiers","entries":[{"key":"dc:identifier.uri","label":"Identifier URI","values":["http://hdl.handle.net/1721.1/107517"]}]},{"id":"additional","label":"Additional Metadata","entries":[{"key":"dc:description","label":"Description","values":["Thesis: M. Eng. in Logistics, Massachusetts Institute of Technology, Supply Chain Management Program, 2016.","Cataloged from PDF version of thesis.","Includes bibliographical references (pages 46-47)."]},{"key":"dc:description.abstract","label":"Abstract","values":["Large pharmaceutical companies struggle to find innovative ways to reduce work-in-process inventory in their production facilities. In our research, we focus on the tradeoff between inventory and production capacity through investing in new facilities and equipment. This tradeoff will depend on the company's objectives and what it is willing to give up in return for reducing inventory. We found that increasing capacity to reduce work-in-process inventory by investing in new facilities is not always the most favorable approach in terms of net present value. However, for flexibility or lead-time improvements, it may make sense to proceed with the investment. We developed multiple scenarios considering the company's future plans to reduce inventory or grow. These scenarios provide insights into the factors that improve the attractiveness of the investments and those that do not. Our financial analysis along with the guidelines and procedures that we have developed help the sponsor company most effectively reach its goal to reduce its work in process inventory."]},{"key":"dc:description.degree","label":"Dc Description Degree","values":["M. Eng. in Logistics"]},{"key":"dc:title","label":"Title","values":["Analyzing tradeoffs between working capital and production capacity for multi-stage manufacturing processes"]}]}],"canonical_facts":{"dc:contributor.advisor":["Jarrod Goentzel."],"dc:contributor.department":["Massachusetts Institute of Technology. Supply Chain Management Program.","Massachusetts Institute of Technology. Engineering Systems Division."],"dc:contributor.other":["Massachusetts Institute of Technology. Engineering Systems Division."],"dc:creator":["Kamareddine, Karim","Yao, Yihong"],"dc:date.accessioned":["2017-03-20T19:38:01Z"],"dc:date.available":["2017-03-20T19:38:01Z"],"dc:date.issued":["2016"],"dc:description":["Thesis: M. Eng. in Logistics, Massachusetts Institute of Technology, Supply Chain Management Program, 2016.","Cataloged from PDF version of thesis.","Includes bibliographical references (pages 46-47)."],"dc:description.abstract":["Large pharmaceutical companies struggle to find innovative ways to reduce work-in-process inventory in their production facilities. In our research, we focus on the tradeoff between inventory and production capacity through investing in new facilities and equipment. This tradeoff will depend on the company's objectives and what it is willing to give up in return for reducing inventory. We found that increasing capacity to reduce work-in-process inventory by investing in new facilities is not always the most favorable approach in terms of net present value. However, for flexibility or lead-time improvements, it may make sense to proceed with the investment. We developed multiple scenarios considering the company's future plans to reduce inventory or grow. These scenarios provide insights into the factors that improve the attractiveness of the investments and those that do not. Our financial analysis along with the guidelines and procedures that we have developed help the sponsor company most effectively reach its goal to reduce its work in process inventory."],"dc:description.degree":["M. Eng. in Logistics"],"dc:identifier.uri":["http://hdl.handle.net/1721.1/107517"],"dc:language.iso":["eng"],"dc:publisher":["Massachusetts Institute of Technology"],"dc:rights":["MIT theses are protected by copyright. They may be viewed, downloaded, or printed from this source but further reproduction or distribution in any format is prohibited without written permission."],"dc:rights.uri":["http://dspace.mit.edu/handle/1721.1/7582"],"dc:subject":["Supply Chain Management Program.","Engineering Systems Division."],"dc:title":["Analyzing tradeoffs between working capital and production capacity for multi-stage manufacturing processes"],"dc:type":["Thesis"]},"updated_at":"2026-07-22T22:21:55Z"}